Delivery Order SPE2DR25D2014-SPE2DR26FA2K1
- Not listed
- The Defense Logistics Agency awarded a $2,492.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 units of Atovaquone-Proguanil 250-100, an antimalarial medication commonly used for malaria prophylaxis in military personnel. Issued on January 12, 2026, with an ultimate completion date of January 13, 2026, this contract represents a routine pharmaceutical procurement executed through DLA's medical supply chain. The award is a non-set-aside contract, indicating open...
- The Defense Logistics Agency awarded a delivery order valued at $1,922.76 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100s, a antimalarial medication commonly used for malaria prophylaxis and treatment in military personnel and Department of Defense beneficiaries. The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a firm fixed price procurement with no set-aside designation, indicating competitive award to this qualified...
- The Defense Logistics Agency awarded a delivery order valued at $5,508.34 to AmerisourceBergen Drug Corp for 100 units of Atovaquone-Proguanil 250-100, an antimalarial medication commonly used by the Department of Defense for malaria prophylaxis in military personnel. This competitively awarded, firm fixed-price delivery order was issued on November 6, 2025, with an ultimate completion date of November 7, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,245.97 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 (100 tablets), a antimalarial medication used primarily for malaria prophylaxis and treatment in military personnel. The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, under firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $13,673.47 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100, a pharmaceutical product typically used for malaria prevention and treatment. The contract was awarded on September 16, 2025, with a completion date of September 17, 2025, and employs firm fixed-price pricing with no set-aside designation, indicating competitive award. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,117.35 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) with an ultimate completion date of August 25, 2025. This firm fixed price, non-set-aside contract was awarded on August 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The antimalarial medication will support federal medical supply requirements, likely for military personnel...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,913.94 for 100 units of Atovaquone-Proguanil 250-100, an antimalarial medication commonly used for malaria prophylaxis and treatment in military and veteran populations. This firm fixed-price delivery order, awarded July 10, 2025, with completion scheduled for July 11, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $15,817.44 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) on December 4, 2025, with completion scheduled for December 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial medication commonly used for malaria prophylaxis and...
- The Defense Logistics Agency awarded a delivery order valued at $5,905.94 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 mg tablets (100 count) on December 3, 2025, with an ultimate completion date of December 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The pharmaceutical product is an antimalarial medication...
- The Defense Logistics Agency awarded a delivery order valued at $6,044.48 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count). This firm fixed-price delivery order is non-set-aside and scheduled for ultimate completion by November 14, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The antimalarial medication will support military and federal healthcare requirements through the agency's...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA2K1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,365.76 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 (100 count), an antimalarial medication commonly used for malaria prophylaxis and treatment in military and federal healthcare settings. The contract was awarded on January 13, 2026, with an ultimate completion date of January 14, 2026, and utilized firm fixed-price pricing with no set-aside designation. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2031), which serves as the primary vehicle for supplying comprehensive pharmaceutical and medical commodities to support military healthcare programs globally. The IDC covers a broad range of medical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, enabling efficient fulfillment of critical pharmaceutical needs for military treatment facilities and federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 1/12/26 |